David Mitchell

机构：Montreal Children's Hospital

发表论文 130 篇 · 总被引 4129 次 · h-index 32

代表论文

• Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome (2018 · Nature Genetics · 被引 221)
• Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria (2019 · Blood · 被引 90)
• Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies (2020 · Blood · 被引 68)
• Correction to Discovery of the Hemifumarate and (α- l -Alanyloxy)methyl Ether as Prodrugs of an Antirheumatic Oxindole: Prodrugs for the Enolic OH Group (2018 · Journal of Medicinal Chemistry · 被引 53)
• Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia (2016 · Haematologica · 被引 53)
• Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression (2018 · Transplantation and Cellular Therapy · 被引 44)